News and Trends 2 Apr 2020 Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop inhaled messenger RNA (mRNA) antibodies that can treat the catastrophic respiratory effects of coronavirus disease, also known as Covid-19. The therapeutic mRNA would be delivered directly into the lungs of symptomatic patients via nebulizers with nanoparticle aerosols. The mRNA could […] April 2, 2020 - 3 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial of a therapeutic vaccine that could offer a new way to treat advanced prostate cancer. In the open-label trial, the University of Oxford spin-off enrolled 23 patients with advanced castration-resistant prostate cancer. The patients received the company’s viral vector vaccine […] March 24, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 18 Mar 2020 OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […] March 18, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email